CUSIP 89422G107 · who reports it, how much, and how much it matters to them
36 of the 720 hedge fund managers we track reported shares of Travere Therapeutics, Inc. (Nasdaq: TVTX) on Form 13F for 30 June 2026. Between them they reported USD 1.3bn. The largest position belongs to Perceptive Advisors, at USD 213m. The manager with the most riding on it is Kynam Capital Management, where it is 6.3% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Perceptive Advisors6 funds on PPLI.com | USD 213m | 3.2% |
| 2 | Adage Capital Management1 fund on PPLI.com | USD 146m | 0.2% |
| 3 | Rock Springs Capital Management2 funds on PPLI.com | USD 124m | 6.0% |
| 4 | Kynam Capital Management1 fund on PPLI.com | USD 114m | 6.3% |
| 5 | Renaissance Technologies13 funds on PPLI.com | USD 104m | 0.1% |
| 6 | Armistice Capital1 fund on PPLI.com | USD 89m | 1.1% |
| 7 | Two Sigma Investments35 funds on PPLI.com | USD 89m | 0.1% |
| 8 | D. E. Shaw & Co.15 funds on PPLI.com | USD 82m | 0.0% |
| 9 | Marshall Wace LLP84 funds on PPLI.com | USD 76m | 0.1% |
| 10 | Eversept Partners3 funds on PPLI.com | USD 45m | 2.4% |
| 11 | POINT72 Asset Management17 funds on PPLI.com | USD 27m | 0.0% |
| 12 | Graham Capital Management18 funds on PPLI.com | USD 25m | 0.5% |
| 13 | Artia Global Partners1 fund on PPLI.com | USD 19m | 3.6% |
| 14 | Capricorn Fund Managers8 funds on PPLI.com | USD 18m | 1.4% |
| 15 | Orbimed Advisors1 fund on PPLI.com | USD 14m | 0.3% |
| 16 | Palo Alto Investors6 funds on PPLI.com | USD 9.5m | 1.3% |
| 17 | Aquatic Capital Management3 funds on PPLI.com | USD 9m | 0.3% |
| 18 | Voleon Capital Management13 funds on PPLI.com | USD 8.3m | 0.2% |
| 19 | Apis Capital Advisors4 funds on PPLI.com | USD 6.4m | 0.6% |
| 20 | Squarepoint Ops7 funds on PPLI.com | USD 6.2m | 0.0% |
| 21 | Exoduspoint Capital Management7 funds on PPLI.com | USD 5.5m | 0.0% |
| 22 | HighVista Strategies27 funds on PPLI.com | USD 4.9m | 1.1% |
| 23 | Millennium Management6 funds on PPLI.com | USD 4.8m | 0.0% |
| 24 | Jain Global1 fund on PPLI.com | USD 2.9m | 0.0% |
| 25 | Engineers Gate Manager1 fund on PPLI.com | USD 2.7m | 0.0% |
| 26 | Walleye Capital8 funds on PPLI.com | USD 2.2m | 0.0% |
| 27 | Citadel Advisors32 funds on PPLI.com | USD 2.2m | 0.0% |
| 28 | Balyasny Asset Management25 funds on PPLI.com | USD 2m | 0.0% |
| 29 | JW Asset Management5 funds on PPLI.com | USD 1.7m | 0.5% |
| 30 | Fora Capital1 fund on PPLI.com | USD 1.6m | 0.1% |
| 31 | Verition Fund Management3 funds on PPLI.com | USD 1.4m | 0.0% |
| 32 | The Quarry1 fund on PPLI.com | USD 571,000 | 0.0% |
| 33 | Tudor Investment Corporation10 funds on PPLI.com | USD 338,000 | 0.0% |
| 34 | Freestone Grove Partners1 fund on PPLI.com | USD 244,000 | 0.0% |
| 35 | Graticule Asia Macro Advisors8 funds on PPLI.com | USD 195,000 | 0.0% |
| 36 | Elequin Capital2 funds on PPLI.com | USD 909 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Kynam Capital Management | USD 114m | 6.3% |
| 2 | Rock Springs Capital Management | USD 124m | 6.0% |
| 3 | Artia Global Partners | USD 19m | 3.6% |
| 4 | Perceptive Advisors | USD 213m | 3.2% |
| 5 | Eversept Partners | USD 45m | 2.4% |
| 6 | Capricorn Fund Managers | USD 18m | 1.4% |
| 7 | Palo Alto Investors | USD 9.5m | 1.3% |
| 8 | HighVista Strategies | USD 4.9m | 1.1% |
| 9 | Armistice Capital | USD 89m | 1.1% |
| 10 | Apis Capital Advisors | USD 6.4m | 0.6% |
Travere Therapeutics, Inc. trades under the symbol TVTX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 89422G107.
36 of the 720 hedge fund managers PPLI.com tracks reported Travere Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Perceptive Advisors (USD 213m), Adage Capital Management (USD 146m), Rock Springs Capital Management (USD 124m), Kynam Capital Management (USD 114m) and Renaissance Technologies (USD 104m).
36 managers in our coverage reported it, and between them they run 377 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Kynam Capital Management, where the position was 6.3% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Travere Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.